June 8th, 2021
May 26th, 2021
On March 2020, the European Commission asked to EFSA the revision of the safety assessment of the food additive titanium dioxide (TiO2 - E 171). EFSA states that genotoxicity concerns after its consumption cannot be excluded after oral ingestion - even though the absorption of titanium dioxide particles is low - as it can be accumulated in the...
May 10th, 2021
In November 2020, the CHMP adopted an Opinion concluding that the outcome of the Article 31 referral on angiotensin-II-receptor antagonists (sartans) containing a tetrazole group (EMEA/H/A-31/1471) should be aligned with the outcome of the Article 5(3) assessment on nitrosamines (EMEA/H/A-5(3)/1490).
May 6th, 2021
ECSIN LAB takes part in the EFSA Scientific Colloquium n° 25: “A coordinated approach to assess the human health risks of micro- and nanoplastics in food”.